Plain-English translation of NCT04576793 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is designed to help researchers understand inflammation in the brain in people with Alzheimer's disease. Researchers will use special brain scans and blood tests to measure inflammation and track how it changes over two years. This information could help develop new ways to treat Alzheimer's in the future.
Alzheimer's disease involves brain inflammation, but we don't yet have good ways to measure it or understand how it affects different types of Alzheimer's. This trial aims to fill that gap by tracking inflammation over time, which could eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have brain scans (including one that uses a special radioactive tracer) and blood tests at the start and again two years later. You may also have a spinal tap to check proteins in your spinal fluid, and genetic testing on your blood. You'll also have thinking and memory tests, and an MRI scan. All of this helps researchers track how inflammation and other brain changes progress over time.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
United States